New research casts doubt on role of fungus in driving pancreatic cancer
03 Aug 2023
Microbial therapy
Four years ago, a report that a common species of fungus might fuel pancreatic cancer offered a promising new view of the deadly disease. But in working to validate the finding, researchers have found no such association.
Four years ago, a report that a common species of fungus might fuel pancreatic cancer offered a promising new view of the deadly disease.
But in working to validate the finding, Duke Health researchers have found no such association. In a study appearing online Aug. 3 in the journal Nature, the Duke researchers conducted a multi-pronged analysis of data from the earlier study and found no link between the pancreatic microbiome and the development of pancreatic cancer.
"We were intrigued by the original finding, as were many research teams," said senior author Peter Allen, M.D., professor in the Department of Surgery and chief of the Division of Surgical Oncology at Duke University School of Medicine.
"There is a growing body of literature connecting the human microbiome to disease, and this was particularly compelling for pancreatic cancer," Allen said. "But our findings did not support an association between fungi and the development of pancreatic cancer in humans."
Allen and colleagues worked to recreate the 2019 findings published in Nature by a different research team. The original study raised hopes that there might be a possible method of preventing pancreatic cancer with the use of antifungals or some other approach to protect from infection.
Focusing on the research team's original raw sequencing data, the Duke researchers were unable to reproduce the findings. Additional studies, using pancreatic cancer tissue in Duke repositories, also failed to produce the original results.
"We believe our findings highlight the challenges of using low biomass samples for microbiome sequencing studies," Allen said. "The inclusion of appropriate negative controls and efforts to identify and remove sequencing contaminants is critical to the interpretation of microbiome data."
In addition to Allen, study authors include Ashley A. Fletcher, Matthew S. Kelly, and Austin M. Eckhoff.
The work was funded by the Duke University School of Medicine through a grant from the Duke Microbiome Center. Kelly and Eckhoff receive funding from the National Institutes of Health (K23-AI135090, T32-CA093245).
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.